Novartis AG's MS Pill Gets First Approval in Russia, U.S. and Others May Follow

Published: Sep 10, 2010

ZURICH, Sept 10 (Reuters) - Swiss drugmaker Novartis (NOVN.VX) has won its first approval for multiple sclerosis (MS) tablet Gilenya in Russia, raising hopes of U.S. Food and Drug Administration (FDA) approval later this month.

Back to news